| Dr Martin Fedko, | |
|
1000 Mineral Point Ave, Janesville, WI 53548-2940 | |
| (608) 756-6611 | |
| (608) 756-6177 |
| Full Name | Dr Martin Fedko |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1000 Mineral Point Ave, Janesville, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134351430 | NPI | - | NPPES |
| ENROLLED | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 54102 (Minnesota) | Secondary |
| 207P00000X | Emergency Medicine | 64551-20 (Wisconsin) | Primary |
| Entity Name | Sanford Health Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699869875 PECOS PAC ID: 6800707100 Enrollment ID: O20040715001116 |
News Archive
BioReference Laboratories, Inc. announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009.
Increasing temperatures, water scarcity, availability of agricultural land, biodiversity loss and climate change threaten to reverse health gains seen over the last century.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
At its 2021 Annual Meeting this month, the Association of Schools and Programs of Public Health (ASPPH) will present the CUNY Graduate School of Public Health and Health Policy with the Harrison C. Spencer Award for Outstanding Community Service.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
› Verified 1 days ago
| Entity Name | United Hospital District Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952307688 PECOS PAC ID: 6204158884 Enrollment ID: O20150422000058 |
News Archive
BioReference Laboratories, Inc. announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009.
Increasing temperatures, water scarcity, availability of agricultural land, biodiversity loss and climate change threaten to reverse health gains seen over the last century.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
At its 2021 Annual Meeting this month, the Association of Schools and Programs of Public Health (ASPPH) will present the CUNY Graduate School of Public Health and Health Policy with the Harrison C. Spencer Award for Outstanding Community Service.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
› Verified 1 days ago
| Entity Name | Carris Health - Redwood Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265914048 PECOS PAC ID: 7911259619 Enrollment ID: O20181129001082 |
News Archive
BioReference Laboratories, Inc. announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009.
Increasing temperatures, water scarcity, availability of agricultural land, biodiversity loss and climate change threaten to reverse health gains seen over the last century.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
At its 2021 Annual Meeting this month, the Association of Schools and Programs of Public Health (ASPPH) will present the CUNY Graduate School of Public Health and Health Policy with the Harrison C. Spencer Award for Outstanding Community Service.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martin Fedko, 1000 Mineral Point Ave, Janesville, WI 53548-2940 Ph: (608) 756-6611 | Dr Martin Fedko, 1000 Mineral Point Ave, Janesville, WI 53548-2940 Ph: (608) 756-6611 |
News Archive
BioReference Laboratories, Inc. announced today it plans to issue earnings results for the third quarter of fiscal 2009 before the open of market trading on Wednesday, September 2, 2009.
Increasing temperatures, water scarcity, availability of agricultural land, biodiversity loss and climate change threaten to reverse health gains seen over the last century.
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
At its 2021 Annual Meeting this month, the Association of Schools and Programs of Public Health (ASPPH) will present the CUNY Graduate School of Public Health and Health Policy with the Harrison C. Spencer Award for Outstanding Community Service.
Concert Pharmaceuticals, Inc. and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced a new collaboration to fund the preclinical advancement of C-21191, a deuterium-modified subtype-selective GABAA modulator developed by Concert with the therapeutic potential of treating spasticity and pain in multiple sclerosis (MS).
› Verified 1 days ago
Michael J. Hartmann, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6111 Fax: 608-756-6177 | |
Dr. Michael V Coogan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6000 | |
Sean William Marquis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6611 Fax: 608-756-6177 | |
Dr. Karl A Nibbelink, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6611 | |
Christopher M. Koenig, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Mineral Point Ave, Janesville, WI 53548 Phone: 608-756-6611 Fax: 608-756-6177 | |
Stephen L Merrill, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3524 E Milwaukee St, Janesville, WI 53546 Phone: 608-756-7100 Fax: 608-756-4700 |